Authors: BAHNSON R BROSMAN S GREENBERG R BROWN BT DALKIN B MIDDLETON R SOLOWAY M STEINBERG G WAJSMAN Z

Citation: R. Bahnson et al., MULTICENTER EFFICACY AND SAFETY STUDY OF INTRAVESICAL AD-32 (VALRUBICIN) IN THE TREATMENT OF PATIENTS WITH REFRACTORY BLADDER-CARCINOMA IN-SITU, The Journal of urology, 159(5), 1998, pp. 551-551

Authors: GARNICK MB GITTELMAN M STEIDEL C CENTENO A KLIMBERG I BROSMAN S MCMURRAY J WIATRAK M TUTTLE J WHITMORE W KUCA B LAVIN P

Citation: Mb. Garnick et al., ABARELIX (PPI-149), A NOVEL AND POTENT GNRH ANTAGONIST, INDUCES A RAPID AND PROFOUND REDUCTION IN PROSTATE-GLAND VOLUME (PGV) AND ANDROGEN LEVELS BEFORE BRACHYTHERAPY (BT) OR RADIATION-THERAPY (XRT), The Journal of urology, 159(5), 1998, pp. 850-850

Authors: ANDRIOLE GL DENIS L BLACKLEDGE G SCHMIDT J SAGALOWSKY A IVERSEN P SOLOWAY M FURR B BLOCK N BANERJEE T YOUNG J KOLVENBAG GCM OESTERLING JE NIEH PTC MONTIE JE SCHELLHAMMER PF BALES GT KLEIN EA BROSMAN S

Citation: Gl. Andriole et al., CLINICAL-TRIALS OF BICALUTAMIDE AS MONOTHERAPY FOR PROSTATE-CANCER - DISCUSSION, Urology, 47(1A), 1996, pp. 48-53

Authors: RICHIE JP SCHELLHAMMER PF SCHER H HAAS G PATTERSON K SAGALOWSKY A KOLVENBAG GJCM KENNEALEY G IVERSEN P BROSMAN S KLEIN EA FURR B BLOCK N DENIS L SCHMIDT J SOLOWAY M OESTERLING JE YOUNG J

Citation: Jp. Richie et al., CLINICAL-DATA ON THE ROLE OF BICALUTAMIDE IN METASTATIC PROSTATE-CANCER - DISCUSSION, Urology, 47(1A), 1996, pp. 80-84

Authors: OESTERLING JE MCLEOD DG RICHIE JP MALKOWICZ SB ANDRIOLE GL SEIDMON J KOLVENBAG GJCM BLACKLEDGE G SCHMIDT J KLEIN EA SOLOWAY M MONTIE JE GOMELLA L HAAS G SCHER H RAMSEY EW BROSMAN S LYNCH D WAJSMAN Z BABAIAN R ROMAS N BLOCK N

Citation: Je. Oesterling et al., THE EXPECTED VALUE OF BICALUTAMIDE IN THE MANAGEMENT OF PROSTATIC DISEASE - DISCUSSION, Urology, 47(1A), 1996, pp. 90-96